Toru Sugiyama

St. Mary's Hospital, 422 Tsubukuhonmachi
Kurume, 8308543, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 154 publications

Efficient PNA double-duplex invasion using preQ1•G-clamp as a pseudo-complementary G•C base pair.

Efficient PNA double-duplex invasion using preQ1•G-clamp as a pseudo-complementary G•C base pair.

Journal: Bioorganic & medicinal chemistry letters

Published: July 06, 2026

Prognostic impact of lymphadenectomy in patients with advanced ovarian clear cell carcinoma: an ancillary analysis of the JGOG3017-A4 study.

Prognostic impact of lymphadenectomy in patients with advanced ovarian clear cell carcinoma: an ancillary analysis of the JGOG3017-A4 study.

Journal: International journal of clinical oncology

Published: May 16, 2025

Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G2/M phase in ovarian cancer.

Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G2/M phase in ovarian cancer.

Journal: Scientific reports

Published: May 16, 2024

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

Journal: Journal of gynecologic oncology

Published: March 13, 2024

Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models.

Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models.

Journal: International journal of clinical oncology

Published: December 27, 2023

A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study).

A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study).

Journal: Cancers

Published: August 29, 2023

Isolation and identification of the new baicalin target protein to develop flavonoid structure-based therapeutic agents.

Isolation and identification of the new baicalin target protein to develop flavonoid structure-based therapeutic agents.

Journal: Bioorganic & medicinal chemistry

Published: March 31, 2023

Synthesis and properties of PNA containing a dicationic nucleobase based on N4-benzoylated cytosine.

Synthesis and properties of PNA containing a dicationic nucleobase based on N4-benzoylated cytosine.

Journal: Bioorganic & medicinal chemistry letters

Published: March 12, 2023

Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study.

Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study.

Journal: Cancer science

Published: November 08, 2022

JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer.

JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer.

Journal: International journal of clinical oncology

Published: May 14, 2022

Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).

Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).

Journal: Gynecologic oncology

Published: December 28, 2021

Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice.

Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice.

Journal: International journal of clinical oncology

Published: December 22, 2021

Showing 1-12 of 154

Last Updated: 09/26/2026